- Home
- TRVG vs BNTC Comparison
TRVG vs BNTC Comparison
Compare TRVG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVG
- BNTC
- Stock Information
- Founded
- TRVG 2005
- BNTC 1995
- Country
- TRVG Germany
- BNTC United States
- Employees
- TRVG N/A
- BNTC N/A
- Industry
- TRVG EDP Services
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- TRVG Technology
- BNTC Health Care
- Exchange
- TRVG Nasdaq
- BNTC Nasdaq
- Market Cap
- TRVG 306.5M
- BNTC 339.8M
- IPO Year
- TRVG N/A
- BNTC N/A
- Fundamental
- Price
- TRVG $5.19
- BNTC $14.67
- Analyst Decision
- TRVG Hold
- BNTC Strong Buy
- Analyst Count
- TRVG 5
- BNTC 7
- Target Price
- TRVG $2.94
- BNTC $24.43
- AVG Volume (30 Days)
- TRVG 123.8K
- BNTC 51.9K
- Earning Date
- TRVG 04-29-2025
- BNTC 05-12-2025
- Dividend Yield
- TRVG N/A
- BNTC N/A
- EPS Growth
- TRVG N/A
- BNTC N/A
- EPS
- TRVG N/A
- BNTC N/A
- Revenue
- TRVG $477,118,749.00
- BNTC N/A
- Revenue This Year
- TRVG $9.85
- BNTC N/A
- Revenue Next Year
- TRVG $6.77
- BNTC N/A
- P/E Ratio
- TRVG N/A
- BNTC N/A
- Revenue Growth
- TRVG N/A
- BNTC N/A
- 52 Week Low
- TRVG $1.60
- BNTC $4.75
- 52 Week High
- TRVG $5.45
- BNTC $16.90
- Technical
- Relative Strength Index (RSI)
- TRVG 69.30
- BNTC 57.19
- Support Level
- TRVG $3.90
- BNTC $14.90
- Resistance Level
- TRVG $5.45
- BNTC $16.90
- Average True Range (ATR)
- TRVG 0.36
- BNTC 1.17
- MACD
- TRVG 0.09
- BNTC 0.05
- Stochastic Oscillator
- TRVG 85.56
- BNTC 57.12
About TRVG trivago N.V.
trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.